Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures

PHASE3CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

November 16, 2016

Primary Completion Date

February 5, 2019

Study Completion Date

December 6, 2021

Conditions
Partial-Onset or Primary Generalized Tonic-Clonic Seizures
Interventions
DRUG

Perampanel

E2007

Trial Locations (91)

Unknown

Facility #1, Little Rock

Facility #1, Palo Alto

Facility #1, Aurora

Facility #1, Gulf Breeze

Facility #1, Loxahatchee Groves

Facility #1, Orlando

Facility #1, Atlanta

Facility #1, Savannah

Facility #1, Boise

Facility #1, Chicago

Facility #1, Urbana

Facility #1, Ames

Facility #1, Wichita

Facility #1, Lexington

Facility #2, Lexington

Facility #1, New Orleans

Facility #1, Duluth

Facility #1, Kansas City

Facility #1, Henderson

Facility #1, Hackensack

Facility #1, Voorhees Township

Facility #1, Brooklyn

Facility #1, Winston-Salem

Facility #1, Cleveland

Facility #1, Memphis

Facility #1, Austin

Facility #1, San Antonio

Facility #1, Tacoma

Facility #1, Milwaukee

Facility #1, Pulderbos

Facility #1, Ottignies

Facility #1, Brussels

Facility #1, La Louvière

Facility #1, Brussels

Facility #1, Calgary

Facility #1, Montreal

Facility #1, Ostrava

Facility #1, Prague

Facility #1, Marseille

Facility #1, Lille

Facility #1, Marseille

Facility #1, Paris

Facility #2, Paris

Facility #1, Strasbourg

Facility #1, Toulouse

Facility #1, Budapest

Facility #2, Budapest

Facility #1, Miskolc

Facility #1, Pécs

Facility #1, Mantova

Facility #1, Calambrone

Facility #1, Bologna

Facility #1, Florence

Facility #1, Milan

Eisai Trial Site #1, Sapporo

Eisai Trial Site #1, Zentsujichó

Eisai Trial Site #1, Sendai

Eisai Trial Site #1, Hamamatsu

Eisai Trial Site #1, Fukuoka

Eisai Trial Site #1, Gifu

Eisai Trial Site #1, Hakodate-shi

Eisai Trial Site #1, Hiroshima

Eisai Trial Site #1, Izumi

Eisai Trial Site #1, Kobe

Eisai Trial Site #1, Kumamoto

Eisai Trial Site #1, Nagoya

Eisai Trial Site #1, Nara

Eisai Trial Site #1, Niigata

Eisai Trial Site #1, Okayama

Eisai Trial Site #1, Osaka

Eisai Trial Site #1, Ōmura

Eisai Trial Site #1, Sagamihara

Eisai Trial Site #1, Sapporo

Eisai Trial Site #1, Shizuoka

Eisai Trial Site #1, Yamagata

Eisai Trial Site #1, Yokohama

Facility #1, Riga

Facility #1, Poznan

Facility #1, Gdansk

Facility #1, Kielce

Facility #1, Daegu

Facility #1, Daejeon

Facility #1, Seoul

Facility #2, Seoul

Facility #3, Seoul

Facility #1, Esplugues de Llobregat

Facility #1, Barcelona

Facility #2, Barcelona

Facility #1, Madrid

Facility #1, Seville

Facility #1, Valencia

All Listed Sponsors
lead

Eisai Inc.

INDUSTRY

NCT02849626 - Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures | Biotech Hunter | Biotech Hunter